PLC Systems to Host Third Quarter Conference Call on November 5, 2007
18 Outubro 2007 - 11:24AM
PR Newswire (US)
FRANKLIN, Mass., Oct. 18 /PRNewswire-FirstCall/ -- PLC Systems Inc.
(AMEX:PLC) announced today that it expects to release to the news
wire its financial results for the third quarter ended September
30, 2007 before the market opens on Monday, November 5, 2007. The
company plans to host a conference call to discuss those results at
11:00 a.m. ET on that same day. The call may be joined via
telephone by dialing (866) 510-0710 or (617) 597-5378 (for
international participants) at least five minutes prior to the
start of the call. The conference ID code is: 62121698. A live
webcast of the conference call will be available by visiting the
PLC Systems website, http://www.plcmed.com/ five minutes before the
call begins. The webcast will be archived on this site starting one
hour after the call is completed. In addition, a telephonic replay
of the call will be available beginning at 1:00 p.m. ET on November
5, 2007, through midnight on November 12, 2007, and can be accessed
by dialing (888) 286-8010 or (617) 801-6888 (for international
participants), using conference ID code 67644934. About PLC Systems
Inc. PLC Systems Inc. is a medical technology company specializing
in innovative technologies for the cardiac and vascular markets.
Headquartered in Franklin, Mass., PLC pioneered the CO2 Heart Laser
System, which cardiac surgeons use to perform CO2 transmyocardial
revascularization (TMR) to alleviate symptoms of severe angina. CO2
TMR offers a treatment option for angina patients who suffer from
severe coronary artery disease. The CO2 Heart Laser is the world's
first TMR angina relief device cleared for commercial distribution
by both the U.S. Food and Drug Administration and Japanese Ministry
of Health, Labor and Welfare, and to obtain a CE Mark for European
distribution. The company is currently conducting a pilot clinical
safety study of its RenalGuard Therapy and RenalGuard System.
RenalGuard Therapy is designed to reduce the toxic effects that
contrast media can have on the kidneys. This therapy is based on
the theory that creating and maintaining a high urine output is
beneficial to patients undergoing imaging procedures where contrast
agents are used. The real-time measurement and matched fluid
replacement design of the RenalGuard System is intended to ensure
that a high urine flow is maintained before, during and after these
procedures. This should allow the body to rapidly eliminate
contrast, reducing its toxic effects. The RenalGuard System with
its matched fluid replacement capability is intended to minimize
the risk of over- or under-hydration. Additional company
information can be found at http://www.plcmed.com/ . PLC Systems,
PLC Medical Systems, PLC, CO2 Heart Laser, RenalGuard, RenalGuard
System and RenalGuard Therapy are trademarks of PLC Systems Inc.
Contact: Mary T. Conway Conway Communications 617-244-9682
DATASOURCE: PLC Systems Inc. CONTACT: Mary T. Conway of Conway
Communications, +1-617-244-9682, , for PLC Systems Inc. Web site:
http://www.plcmed.com/
Copyright
P L C Systems (AMEX:PLC)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
P L C Systems (AMEX:PLC)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
Notícias em tempo-real sobre Plc Systems, da American Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Plc Systems,